07:00 , Jul 11, 2016 |  BC Week In Review  |  Financial News

Cellect Biomed proposes follow-on

Cellect Biomed Ltd. (Tel Aviv:CLBD), Tel Aviv, Israel   Business: Gene/Cell therapy   Date announced: 2016-07-07   Type: Follow-on   To be raised: Up to $10 million   Shares: TBD   Price prior: NIS1.59  ...
07:00 , Apr 25, 2016 |  BC Week In Review  |  Company News

Cellect Biomed, Accellta deal

Cellect granted Accellta non-exclusive rights to evaluate apoptotic induction-based technology. Accellta will evaluate if the technology can grow its pluripotent stem cells “safely and in a shorter time.” Cellect will receive an upfront payment of...
08:00 , Feb 22, 2016 |  BC Week In Review  |  Financial News

Cellect Biomed completes private placement

Cellect Biomed Ltd. (Tel Aviv:CLBD), Tel Aviv, Israel   Business: Gene/Cell therapy   Date completed: 2016-02-16   Type: Private placement   Raised: NIS8 million ($2.1 million)   Price: NIS1.39   Shares outstanding prior: 75.9 million...